These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35595574)

  • 21. Ultra-specific nucleic acid testing by target-activated nucleases.
    Fu J; Li J; Chen J; Li Y; Liu J; Su X; Shi S
    Crit Rev Biotechnol; 2022 Nov; 42(7):1061-1078. PubMed ID: 34706599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].
    Tan JJ; Peng YZ; Huang GT
    Zhonghua Shao Shang Za Zhi; 2021 Jul; 37(7):681-687. PubMed ID: 34304411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas enzymes: The toolkit revolutionizing diagnostics.
    Verosloff MS; Shapiro SJ; Hawkins EM; Alpay E; Verma D; Stanfield EG; Kreindler L; Jain S; McKay B; Hubbell SA; Hendriks CG; Blizard BA; Broughton JP; Chen JS
    Biotechnol J; 2022 Jul; 17(7):e2100304. PubMed ID: 34505742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advancing sensing technology with CRISPR: From the detection of nucleic acids to a broad range of analytes - A review.
    Xie S; Ji Z; Suo T; Li B; Zhang X
    Anal Chim Acta; 2021 Nov; 1185():338848. PubMed ID: 34711331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial production of chemicals driven by CRISPR-Cas systems.
    Shi S; Qi N; Nielsen J
    Curr Opin Biotechnol; 2022 Feb; 73():34-42. PubMed ID: 34303184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing CRISPR/Cas systems with nanotechnology.
    Chowdhry R; Lu SZ; Lee S; Godhulayyagari S; Ebrahimi SB; Samanta D
    Trends Biotechnol; 2023 Dec; 41(12):1549-1564. PubMed ID: 37451945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogen detection in the CRISPR-Cas era.
    Sashital DG
    Genome Med; 2018 Apr; 10(1):32. PubMed ID: 29690921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CRISPR-Cas system in molecular diagnostics.
    Song R; Chen Z; Xiao H; Wang H
    Clin Chim Acta; 2024 Jul; 561():119820. PubMed ID: 38901631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances and challenges of the use of the CRISPR/Cas system as a non-nucleic acid molecular diagnostic.
    Zhou J; Ren XM; Wang X; Li Z; J Xian C
    Heliyon; 2023 Dec; 9(12):e22767. PubMed ID: 38076202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids.
    Mukama O; Wu J; Li Z; Liang Q; Yi Z; Lu X; Liu Y; Liu Y; Hussain M; Makafe GG; Liu J; Xu N; Zeng L
    Biosens Bioelectron; 2020 Jul; 159():112143. PubMed ID: 32364943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signal amplification and output of CRISPR/Cas-based biosensing systems: A review.
    Wang SY; Du YC; Wang DX; Ma JY; Tang AN; Kong DM
    Anal Chim Acta; 2021 Nov; 1185():338882. PubMed ID: 34711321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CRISPR Revolution: Unraveling the mysteries of Life's genetic code.
    Harsij Z; Ghafoorzadeh Z; Goharian E
    Gene; 2024 Jan; 892():147870. PubMed ID: 37797781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas12-based nucleic acids detection systems.
    Leung RK; Cheng QX; Wu ZL; Khan G; Liu Y; Xia HY; Wang J
    Methods; 2022 Jul; 203():276-281. PubMed ID: 33662563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas system and its use in the diagnosis of infectious diseases.
    Padmanaban V; Ranganathan UDK
    Microbiol Res; 2022 Oct; 263():127100. PubMed ID: 35849921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology.
    Roueinfar M; Templeton HN; Sheng JA; Hong KL
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-based diagnostics.
    Kaminski MM; Abudayyeh OO; Gootenberg JS; Zhang F; Collins JJ
    Nat Biomed Eng; 2021 Jul; 5(7):643-656. PubMed ID: 34272525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas Powered Multiplexed Biosensing.
    Bruch R; Urban GA; Dincer C
    Trends Biotechnol; 2019 Aug; 37(8):791-792. PubMed ID: 31078316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CRISPR-Cas toolbox and gene editing technologies.
    Liu G; Lin Q; Jin S; Gao C
    Mol Cell; 2022 Jan; 82(2):333-347. PubMed ID: 34968414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.